Compugen LtdCGEN
Price$2.34Intrinsic value$5.66142% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $72.8M+161.1% YoYTTM through 31 Dec 2025
Net Income $35.3MTTM through 31 Dec 2025
Free Cash Flow $31.3MTTM through 31 Dec 2025

Margins

Current
Gross Margin16.1%
EBITDA Margin43.7%
Operating Margin-413.6%
Net Margin48.6%

Returns

36.6%ROE
23.9%ROA
36.6%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio6.23x
Net Debt-$134.9Mnet cash position
Cash & Equivalents$90.6M

Quality Metrics

Altman Z-Score0.66
Piotroski F-Score6 / 9
FCF Margin43.1%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'18'20'21'22'23'24'25
FY2025: $72.8M
Diluted EPS$0.38TTM
'19'20'21'22'23'24'25
FY2025: $0.38

Dividend

No dividend

Capital Allocation

R&D Spend$22.8M
Capex Intensity0.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.